Skip to main content
Clinical Trials/IRCT20160717028967N7
IRCT20160717028967N7
Not yet recruiting
Phase 2

The efficacy of duloxetinein the treatment of depression, withdrawal symptoms, craving for methamphetamine compared with placebo (clinical trial with a control group)

Kermanshah University of Medical Sciences0 sites66 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Methamphetamine dependency.
Sponsor
Kermanshah University of Medical Sciences
Enrollment
66
Status
Not yet recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Gender Male
  • Methamphetamine dependence diagnoses accordingly Diagnostic and Statistical Manual of Mental Disorders fifth edition
  • The dominant use of methamphetamine for at least 6 months
  • lack of serious psychiatric disorders

Exclusion Criteria

  • subjects who met opiates dependence
  • non compliance or not willing for continuing the study
  • sever and unbearable drug side effect even after reducing the dose.

Outcomes

Primary Outcomes

Not specified

Similar Trials